2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Gerstein, Hertzel, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Study of Atherosclerosis With Ramipril and Rosiglitazone Ramipril, Rosiglitazone - Atherosclerosis, Impaired Glucose Tolerance | Phase 3 | Completed | Gerstein, Hertzel, MD | 1200 | 2001-07-01 | 2008-08-25 |
| The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial Ramipril, Rosiglitazone - Impaired Glucose Tolerance, Cardiovascular Disease | Phase 3 | Completed | Gerstein, Hertzel, MD | 5000 | 2001-07-01 | 2009-11-10 |
Cardiovascular Diseases (2) · Glucose Intolerance (2) · Atherosclerosis (1) · Glucose Metabolism Disorders (1)
Ramipril (2) · Rosiglitazone (2)
Eva Lonn, MD (1) · Hertzel Gerstein, MD (1) · Salim Yusuf, MD (1)
PMID 16980380, PMID 16997664, PMID 18268075, PMID 19477351, PMID 21515846, PMID 38682786